231 related articles for article (PubMed ID: 12944494)
1. Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.
Gu JJ; Tolin AK; Jain J; Huang H; Santiago L; Mitchell BS
Mol Cell Biol; 2003 Sep; 23(18):6702-12. PubMed ID: 12944494
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene.
Gu JJ; Stegmann S; Gathy K; Murray R; Laliberte J; Ayscue L; Mitchell BS
J Clin Invest; 2000 Aug; 106(4):599-606. PubMed ID: 10953035
[TBL] [Abstract][Full Text] [Related]
3. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
[TBL] [Abstract][Full Text] [Related]
4. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.
Dayton JS; Lindsten T; Thompson CB; Mitchell BS
J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505
[TBL] [Abstract][Full Text] [Related]
5. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
6. Immune Response-Dependent Assembly of IMP Dehydrogenase Filaments.
Calise SJ; Abboud G; Kasahara H; Morel L; Chan EKL
Front Immunol; 2018; 9():2789. PubMed ID: 30555474
[TBL] [Abstract][Full Text] [Related]
7. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
[TBL] [Abstract][Full Text] [Related]
8. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
9. Increased riboflavin production by manipulation of inosine 5'-monophosphate dehydrogenase in Ashbya gossypii.
Buey RM; Ledesma-Amaro R; Balsera M; de Pereda JM; Revuelta JL
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9577-89. PubMed ID: 26150243
[TBL] [Abstract][Full Text] [Related]
10. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
11. IMPDH forms the cytoophidium in zebrafish.
Keppeke GD; Chang CC; Antos CL; Peng M; Sung LY; Andrade LEC; Liu JL
Dev Biol; 2021 Oct; 478():89-101. PubMed ID: 34048735
[TBL] [Abstract][Full Text] [Related]
12. Regulation of GTP biosynthesis.
Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
[TBL] [Abstract][Full Text] [Related]
13. The CBS subdomain of inosine 5'-monophosphate dehydrogenase regulates purine nucleotide turnover.
Pimkin M; Markham GD
Mol Microbiol; 2008 Apr; 68(2):342-59. PubMed ID: 18312263
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Barnes BJ; Eakin AE; Izydore RA; Hall IH
Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
[TBL] [Abstract][Full Text] [Related]
15. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
16. On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa.
Aherne A; Kennan A; Kenna PF; McNally N; Lloyd DG; Alberts IL; Kiang AS; Humphries MM; Ayuso C; Engel PC; Gu JJ; Mitchell BS; Farrar GJ; Humphries P
Hum Mol Genet; 2004 Mar; 13(6):641-50. PubMed ID: 14981049
[TBL] [Abstract][Full Text] [Related]
17. Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
Barnes BJ; Izydore RA; Eakin AE; Hall IH
J Pharmacol Exp Ther; 2001 Aug; 298(2):790-6. PubMed ID: 11454943
[TBL] [Abstract][Full Text] [Related]
18. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil.
Devyatko E; Zuckermann A; Bohdjalian A; Roedler S; Dunkler D; Grimm M; Weigel G
Transplantation; 2006 Jul; 82(1):113-8. PubMed ID: 16861950
[TBL] [Abstract][Full Text] [Related]
19. The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases.
Buey RM; Fernández-Justel D; Jiménez A; Revuelta JL
Protein Sci; 2022 Sep; 31(9):e4399. PubMed ID: 36040265
[TBL] [Abstract][Full Text] [Related]
20. A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.
Fernández-Justel D; Núñez R; Martín-Benito J; Jimeno D; González-López A; Soriano EM; Revuelta JL; Buey RM
J Mol Biol; 2019 Mar; 431(5):956-969. PubMed ID: 30664871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]